Primary human colon cancer cells and high-grade adenomas are sensitive to TRAIL and combinational chemotherapies (e.g., using chloroquine and shogaol with TRAIL) could inhibit the proliferation of colon cells more effectively [12–16]. The gene discussed is TNFSF10; the disease is colonic neoplasm.